Increased Protein Intake (Eggs) for Cancer Recovery
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment of increased protein intake (eggs) for cancer recovery?
Is it safe for cancer survivors to increase protein intake through egg consumption?
The research does not specifically address the safety of increased egg consumption for cancer survivors, but it highlights that dietary changes and supplement use are common among cancer survivors, often without medical supervision. It's important for patients to discuss any dietary changes with their healthcare provider to avoid potentially harmful practices.16789
How does the egg supplementation treatment for cancer recovery differ from other treatments?
The egg supplementation treatment is unique because it involves increasing protein intake through the consumption of eggs, which may help improve muscle mass and strength in cancer patients. Unlike other treatments that might focus on medication or surgery, this approach uses a dietary intervention to potentially enhance recovery and quality of life.1381011
What is the purpose of this trial?
Cancer and its treatments often result in severe toxicities and side effects that, over the course of treatment, results in weight loss and depletion of key nutrients. Loss of muscle mass and strength during cancer treatment is a critical problem because it negatively affects patient response and tolerance to therapy and post-treatment recovery. To restore the nutritional status, it is imperative to stimulate muscle protein anabolism. Eggs are high quality protein source, popular and well tolerated by cancer patients. Therefore, the objective of this study is to determine whether a nutritional intervention of ≥2 eggs can aid in restoring nutritional status and improving immune function and quality of life of cancer patients' post-treatment. It is an 8- week randomised clinical trial with parallel arm assignment. Half of the participants will receive the nutritional intervention (Early Intervention) and the other half will be on standard of care or usual diet for first 4 weeks. Starting from week 5, all participants will receive the nutrition intervention till week 8 (Delayed Intervention). Dietary intake (foods and nutrients), cumulative protein intake (g protein/kg body weight), immunological measures, physical performance and quality of life has been planned to be assessed over time and between groups to evaluate the feasibility of an egg intervention in meeting recommended protein intakes for patients with cancer.
Research Team
Vera Mazurak, PhD
Principal Investigator
University of Alberta
Eligibility Criteria
This trial is for adults over 18 who've finished platinum chemotherapy for cancer, can eat on their own, and are willing to follow the study plan. It's not for those allergic to eggs, fed by tubes or IV nutrition, with brain cancer or conditions affecting food consumption or nutrient metabolism.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Early Intervention
Participants receive a nutritional intervention of ≥2 eggs immediately after the completion of treatment for 8 weeks
Delayed Intervention
Participants receive a nutritional intervention of ≥2 eggs starting 4 weeks after the completion of treatment, for 4 weeks
Follow-up
Participants are monitored for changes in body weight, protein intake, energy intake, quality of life, nutritional status, symptom severity, and physical performance
Treatment Details
Interventions
- ≥ 2 eggs in addition to usual diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Egg Farmers of Canada
Collaborator